Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias

Neuroscience Letters

Volumn 418, Issue 1, 2007, Pages 72-76

  Magaki, Shino ^a   Raghavan, Ravi ^a   Mueller, Claudius ^a   Oberg, Kerby C ^a   Vinters, Harry V ^b   Kirsch, Wolff M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Loosely bound iron; Non heme iron

Indexed keywords

AMYLOID; COPPER; IRON; IRON REGULATORY PROTEIN 2; MYELIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; COPPER METABOLISM; DEMENTIA; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRON METABOLISM; LEWY BODY; MALE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN CHEMISTRY; COPPER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRON; IRON REGULATORY PROTEIN 2; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; SENILE PLAQUES;

EID: 34247120546     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.02.077     Document Type: Article

References (30)

1. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25 (2004) 5-18
2. Bartzokis G., Sultzer D., Lu P.H., Nuechterlein K.H., Mintz J., and Cummings J.L. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol. Aging 25 (2004) 843-851
3. Basun H., Forssell L.G., Wetterberg L., and Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J. Neural Transm. Park Dis. Dement. Sect. 3 (1991) 231-258
4. Bayer T.A., and Multhaup G. Involvement of amyloid beta precursor protein (AbetaPP) modulated copper homeostasis in Alzheimer's disease. J. Alzheimers Dis. 8 (2005) 201-206
5. Benes F.M. A disturbance of late myelination as a trigger for Alzheimer's disease. Neurobiol. Aging 25 (2004) 41-43
6. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003) 207-214
7. Connor J.R. Myelin breakdown in Alzheimer's disease: a commentary. Neurobiol. Aging 25 (2004) 45-47
8. Connor J.R., Snyder B.S., Beard J.L., Fine R.E., and Mufson E.J. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31 (1992) 327-335
9. Deibel M.A., Ehmann W.D., and Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143 (1996) 137-142
10. Friedman A., Galazka-Friedman J., Bauminger E.R., and Koziorowski D. Iron and ferritin in hippocampal cortex and substantia nigra in human brain-implications for the possible role of iron in dementia. J. Neurol. Sci. 248 (2006) 31-34
11. Gutteridge J.M. Iron and oxygen radicals in brain. Ann. Neurol. 32 (1992) S16-S21
12. Hallgren B., and Sourander P. The non-haemin iron in the cerebral cortex in Alzheimer's disease. J. Neurochem. 5 (1960) 307-310
13. Halliwell B., and Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219 (1984) 1-14
14. Hu J., and Connor J.R. Demonstration and characterization of the iron regulatory protein in human brain. J. Neurochem. 67 (1996) 838-844
15. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., and Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 9 (2004) 954-960
16. Kala S.V., Hasinoff B.B., and Richardson J.S. Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. Int. J. Neurosci. 86 (1996) 263-269
17. Levenson C.W., and Tassabehji N.M. Iron and ageing: an introduction to iron regulatory mechanisms. Ageing Res. Rev. 3 (2004) 251-263
18. Loeffler D.A., Connor J.R., Juneau P.L., Snyder B.S., Kanaley L., DeMaggio A.J., Nguyen H., Brickman C.M., and LeWitt P.A. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J. Neurochem. 65 (1995) 710-724
19. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., and Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158 (1998) 47-52
20. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., White A.R., Beyreuther K., Masters C.L., Bush A.I., and Li Q.X. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277 (2002) 44670-44676
21. Nelson S.R., Pazdernik T.L., and Samson F.E. Measurement of loosely-bound iron in brain regions using redox cycling and salicylate. Cell Mol. Biol. (Noisy-le-grand) 46 (2000) 649-655
22. Perry G., Sayre L.M., Atwood C.S., Castellani R.J., Cash A.D., Rottkamp C.A., and Smith M.A. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 6 (2002) 339-352
23. Religa D., Strozyk D., Cherny R.A., Volitakis I., Haroutunian V., Winblad B., Naslund J., and Bush A.I. Elevated cortical zinc in Alzheimer disease. Neurology 67 (2006) 69-75
24. Rottkamp C.A., Raina A.K., Zhu X., Gaier E., Bush A.I., Atwood C.S., Chevion M., Perry G., and Smith M.A. Redox-active iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30 (2001) 447-450
25. Sjobeck M., and Englund E. Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Neuropathol. Appl. Neurobiol. 29 (2003) 159-169
26. Smith M.A., Wehr K., Harris P.L., Siedlak S.L., Connor J.R., and Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res. 788 (1998) 232-236
27. Smith M.A., Harris P.L., Sayre L.M., and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9866-9868
28. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., and Rossini P.M. Elevation of serum copper levels in Alzheimer's disease. Neurology 59 (2002) 1153-1161
29. Wallander M.L., Leibold E.A., and Eisenstein R.S. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim. Biophys. Acta 1763 (2006) 668-689
30. Wang D.S., Bennett D.A., Mufson E.J., Mattila P., Cochran E., and Dickson D.W. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci. Res. 48 (2004) 93-100